Financials
- Market Capitalization 532.97 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.25
Relación precio/flujo de caja
1.9
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2451 | CSTL Castle Biosciences, Inc. - Common stock | 32.77 USD | -2.18% | -4.32% | +17.75% | +33.13% | 1.00 B USD | ||
| 2521 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.05 USD | +0.67% | -5.62% | +16.57% | +211.86% | 890.55 M USD | ||
| 2995 | PRE Prenetics Global Limited - Class A Ordinary Share | 26.25 USD | +1.90% | +17.98% | +34.96% | +232.28% | 442.94 M USD | ||
| 3299 | MYGN Myriad Genetics, Inc. - Common Stock | 3.22 USD | +1.90% | +5.23% | +12.59% | -61.06% | 307.99 M USD |